EIY2.F · Relay Medical Corp

-

Please sign in to comment on EIY2.F

1 Comment

Admin

4 years, 1 month ago

Relay Medical Corp is currently in a long term downtrend where the price is trading 31.4% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Relay Medical Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 205.7% to $-2M since the same quarter in the previous year.

Finally, its free cash flow fell by 291.8% to $-1M since the same quarter in the previous year.

Based on the above factors, Relay Medical Corp gets an overall score of 1/5.

Exchange	F
CurrencyCode	EUR
ISIN	None
Sector	Healthcare
Industry	Diagnostics & Research

Market Cap	33M
PE Ratio	None
Beta	0.5
Target Price	None
Dividend Yield	None

ABOUT

Relay Medical Corp

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company provides Fionet, a mobile testing and tracking platform, which combines handheld devices linked to online AI-powered cloud, automating frontline testing, and capturing test results for tracking; HemoPalm, a blood analyzer and single-use cartridge that provides enterprise solution for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an user experience -centric system design to improve management and identification of medications. It offers techno-commercial leadership and support services for the venture that pursue technology opportunities in the medicinal cannabis, agrotechnology, and other related industries. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.

EIY2.F · Relay Medical Corp

-

Relay Medical Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Relay Medical Corp using a moving average strategy